Free Trial

Corbus Pharmaceuticals (CRBP) SEC Filings & 10K Form

Corbus Pharmaceuticals logo
$7.79 +0.27 (+3.59%)
Closing price 04:00 PM Eastern
Extended Trading
$7.78 -0.01 (-0.13%)
As of 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Corbus Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/01/2025
3:35 PM
Corbus Pharmaceuticals (Filer)
Form DEF 14A
04/01/2025
3:36 PM
Corbus Pharmaceuticals (Filer)
Form DEFA14A
04/01/2025
3:38 PM
Corbus Pharmaceuticals (Filer)
Form ARS
03/21/2025
3:40 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
3:45 PM
Corbus Pharmaceuticals (Issuer)
Hodgson Ian (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/18/2025
3:30 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2025
4:24 PM
Corbus Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2025
7:30 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2025
3:30 PM
Corbus Pharmaceuticals (Issuer)
Smethurst Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
3:30 PM
Corbus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
3:16 PM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
7:05 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:48 PM
Corbus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
11/14/2024
5:41 PM
Corbus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G
11/14/2024
2:09 PM
Corbus Pharmaceuticals (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G/A
11/12/2024
1:34 PM
Corbus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
8:37 AM
Adage Capital Management, L.P. (Filed by)
Corbus Pharmaceuticals (Subject)
Form SC 13G/A
11/07/2024
3:58 PM
Corbus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
7:41 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
10:28 AM
Corbus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
6:51 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
Corbus Pharmaceuticals (Subject)
Form SC 13G
10/15/2024
3:19 PM
Corbus Pharmaceuticals (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
09/24/2024
3:04 PM
Chen Bihua (Reporting)
Corbus Pharmaceuticals (Issuer)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
3:44 PM
CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
3:52 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:45 PM
Corbus Pharmaceuticals (Issuer)
Kung Winston (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/20/2024
3:48 PM
Corbus Pharmaceuticals (Issuer)
Kung Winston (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
7:15 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
3:42 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
4:58 PM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
4:59 PM
Corbus Pharmaceuticals (Issuer)
Moran Sean F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
8:21 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
4:25 PM
Cohen Yuval (Reporting)
Corbus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/14/2024
4:25 PM
Corbus Pharmaceuticals (Subject)
Moran Sean F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2024
3:30 PM
Corbus Pharmaceuticals (Issuer)
Salzmann Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:31 PM
CATLIN AVERY W (Reporting)
Corbus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:32 PM
Corbus Pharmaceuticals (Issuer)
Jenkins John Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
6:08 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
3:39 PM
Corbus Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/20/2024
3:30 PM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad)

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.
05/09/2024
7:00 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:30 AM
Corbus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CRBP) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners